rAAVen to Present at Viral Vector Summit in Amsterdam

rAAVen Therapeutics will participate in the Viral Vector Formulation Process & Development Summit in Amsterdam 11-13 June. Our CSO, Patrick Aldrin-Kirk, will present the rAAVen platform, and what makes us the go to alternative when it comes to novel AAV capsid engineering. (link)